Night-to-night sleep variability in older adults with chronic insomnia: Mediators and moderators in a randomized controlled trial of brief behavioral therapy (BBT-I)

  • Wai Sze Chan
  • , Jacob Williams
  • , Natalie D. Dautovich
  • , Joseph P.H. McNamara
  • , Ashley Stripling
  • , Joseph M. Dzierzewski
  • , Richard B. Berry
  • , Karin J.M. McCoy
  • , Christina S. McCrae

Research output: Contribution to journalArticlepeer-review

Abstract

Study Objectives: Sleep variability is a clinically significant variable in understanding and treating insomnia in older adults. The current study examined changes in sleep variability in the course of brief behavioral therapy for insomnia (BBT-I) in older adults who had chronic insomnia. Additionally, the current study examined the mediating mechanisms underlying reductions of sleep variability and the moderating effects of baseline sleep variability on treatment responsiveness. Methods: Sixty-two elderly participants were randomly assigned to either BBT-I or self-monitoring and attention control (SMAC). Sleep was assessed by sleep diaries and actigraphy from baseline to posttreatment and at 3-month follow-up. Mixed models were used to examine changes in sleep variability (within-person standard deviations of weekly sleep parameters) and the hypothesized mediation and moderation effects. Results: Variabilities in sleep diary-assessed sleep onset latency (SOL) and actigraphy-assessed total sleep time (TST) significantly decreased in BBT-I compared to SMAC (Pseudo R2 = .12, .27; P = .018, .008). These effects were mediated by reductions in bedtime and wake time variability and time in bed. Significant time × group × baseline sleep variability interactions on sleep outcomes indicated that participants who had higher baseline sleep variability were more responsive to BBT-I; their actigraphy-assessed TST, SOL, and sleep efficiency improved to a greater degree (Pseudo R2 = .15 to .66; P < .001 to .044). Conclusions: BBT-I is effective in reducing sleep variability in older adults who have chronic insomnia. Increased consistency in bedtime and wake time and decreased time in bed mediate reductions of sleep variability. Baseline sleep variability may serve as a marker of high treatment responsiveness to BBT-I. Clinical Trial Registration: ClinicalTrials.gov, Identifier: NCT02967185.

Original languageEnglish
Pages (from-to)1243-1254
Number of pages12
JournalJournal of Clinical Sleep Medicine
Volume13
Issue number11
DOIs
StatePublished - 2017

Funding

The project described was supported by Award Number AG024459 (Christina S. McCrae, PhD, PI) from the National Institute on Aging (NIA). Additional support was provided by an Institutional Training Grant Award Number AG020499 (Michael Marsiske, PhD, Director) from the NIA

FundersFunder number
National Institute on AgingAG024459 , AG020499

    ASJC Scopus Subject Areas

    • Pulmonary and Respiratory Medicine
    • Neurology
    • Clinical Neurology

    Keywords

    • CBT-I
    • Insomnia
    • Mechanisms of change
    • Older adults
    • Sleep variability
    • Treatment efficacy moderator

    Disciplines

    • Medicine and Health Sciences
    • Neurology

    Fingerprint

    Dive into the research topics of 'Night-to-night sleep variability in older adults with chronic insomnia: Mediators and moderators in a randomized controlled trial of brief behavioral therapy (BBT-I)'. Together they form a unique fingerprint.

    Cite this